Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Reduction of antibiotic prescriptions for acute respiratory tract infections in primary care: a systematic review.

Köchling A, Löffler C, Reinsch S, Hornung A, Böhmer F, Altiner A, Chenot JF.

Implement Sci. 2018 Mar 20;13(1):47. doi: 10.1186/s13012-018-0732-y.

2.

Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis.

Johansson T, Abuzahra ME, Keller S, Mann E, Faller B, Sommerauer C, Höck J, Löffler C, Köchling A, Schuler J, Flamm M, Sönnichsen A.

Br J Clin Pharmacol. 2016 Aug;82(2):532-48. doi: 10.1111/bcp.12959. Epub 2016 May 7. Review.

3.

Converting habits of antibiotic prescribing for respiratory tract infections in German primary care--the cluster-randomized controlled CHANGE-2 trial.

Altiner A, Berner R, Diener A, Feldmeier G, Köchling A, Löffler C, Schröder H, Siegel A, Wollny A, Kern WV.

BMC Fam Pract. 2012 Dec 20;13:124. doi: 10.1186/1471-2296-13-124.

4.

[Family therapy within the treatment of eating disorders].

Schrauth M, Nikendei C, Köchling A, Martens U, Herzog W, Zipfel S.

Ther Umsch. 2006 Aug;63(8):551-4. Review. German.

PMID:
16941401
5.

Severe respiratory syncytial virus infections and reduced interferon-gamma generation in vitro.

Schauer U, Hoffjan S, Rothoeft T, Bartz H, Konig S, Fuchs E, Bittscheidt J, Kochling A, Stephan V.

Clin Exp Immunol. 2004 Oct;138(1):102-9.

6.

RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life.

Schauer U, Hoffjan S, Bittscheidt J, Köchling A, Hemmis S, Bongartz S, Stephan V.

Eur Respir J. 2002 Nov;20(5):1277-83.

7.

[Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases].

Wappler F, Scholz J, von Richthofen V, Fiege M, Köchling A, Matschke J, Winkler G, Schulte am Esch J.

Anasthesiol Intensivmed Notfallmed Schmerzther. 1998 Jun;33(6):373-80. German.

PMID:
9689395
8.

Rhabdomyolysis following severe physical exercise in a patient with predisposition to malignant hyperthermia.

Köchling A, Wappler F, Winkler G, Schulte am Esch JS.

Anaesth Intensive Care. 1998 Jun;26(3):315-8.

9.

Attenuation of serotonin-induced contractures in skeletal muscle from malignant hyperthermia-susceptible patients with dantrolene.

Wappler F, Scholz J, von Richthofen V, Fiege M, Köchling A, Lambrecht W, Schulte am Esch J.

Acta Anaesthesiol Scand. 1997 Nov;41(10):1312-8.

PMID:
9422298
10.

Inositol 1,4,5-trisphosphate in blood and skeletal muscle in human malignant hyperthermia.

Wappler F, Scholz J, Köchling A, Steinfath M, Krause T, Schulte am Esch J.

Br J Anaesth. 1997 May;78(5):541-7.

11.

[Are monamine oxidase inhibitors in disposition to malignant hyperthermia contraindicated? Discussion based on a case report].

Wappler F, Köchling A, Roewer N.

Anasthesiol Intensivmed Notfallmed Schmerzther. 1996 Aug;31(6):349-53. German.

PMID:
8962929
12.

Fulminant malignant hyperthermia associated with ketoacidotic diabetic coma.

Wappler F, Roewer N, Köchling A, Braune H, Reissinger T, Schulte am Esch J.

Intensive Care Med. 1996 Aug;22(8):809-12.

PMID:
8880251
13.

Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.

Wappler F, Roewer N, Köchling A, Scholz J, Löscher W, Steinfath M.

Anesthesiology. 1996 Jun;84(6):1280-7.

PMID:
8669667
14.

In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles.

Wappler F, Roewer N, Köchling A, Scholz J, Steinfath M, Schulte am Esch J.

Anesth Analg. 1996 Jun;82(6):1230-6.

PMID:
8638796
15.

[Effects of serotonin 2 receptor agonists on skeletal muscle preparations in patients with a disposition toward malignant hyperthermia].

Wappler F, Roewer N, Köchling A, Scholz J, Steinfath M, Rumberger E, Löscher W, Schulte am Esch J.

Anaesthesist. 1995 Aug;44(8):538-44. German.

PMID:
7573901
16.

Modulation of ryanodine-induced contractures in human skeletal muscle pretreated with dantrolene.

Lenzen C, Roewer N, Wappler F, Köchling A, Steinfath M, Scholz J, Schulte am Esch J.

Acta Anaesthesiol Scand. 1995 Apr;39(3):343-6.

PMID:
7793213
17.

C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.

Steinfath M, Singh S, Scholz J, Becker K, Lenzen C, Wappler F, Köchling A, Roewer N, Schulte am Esch J.

J Mol Med (Berl). 1995 Jan;73(1):35-40.

PMID:
7633940
18.

High-purity ryanodine and 9,21-dehydroryanodine for in vitro diagnosis of malignant hyperthermia in man.

Wappler F, Roewer N, Lenzen C, Köchling A, Scholz J, Steinfath M, Schulte am Esch J.

Br J Anaesth. 1994 Feb;72(2):240-2.

19.

Cytotoxicity of 2-bromo-(N-acetylcystein-S-yl)-hydroquinone isomers in rat renal tubular epithelial cells.

Koob M, Köchling A, Weber S, Lau SS, Monks TJ, Dekant W.

Toxicol Lett. 1990 Sep;53(1-2):143-5. No abstract available.

PMID:
2219154
20.

A mechanism of haloalkene-induced renal carcinogenesis.

Dekant W, Vamvakas S, Koob M, Köchling A, Kanhai W, Müller D, Henschler D.

Environ Health Perspect. 1990 Aug;88:107-10. Review.

21.

Cytotoxicity of cysteine S-conjugates: structure-activity relationships.

Vamvakas S, Köchling A, Berthold K, Dekant W.

Chem Biol Interact. 1989;71(1):79-90.

PMID:
2776234

Supplemental Content

Loading ...
Support Center